• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: PRO.

作者信息

Macon Conrad J, Ellison David H

机构信息

Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon.

Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, Oregon.

出版信息

Kidney360. 2024 Aug 1;5(8):1072-1074. doi: 10.34067/KID.0000000000000422. Epub 2024 Apr 9.

DOI:10.34067/KID.0000000000000422
PMID:38595193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11371343/
Abstract
摘要

相似文献

1
Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: PRO.托拉塞米是心力衰竭患者更合适的口服袢利尿剂：PRO。
Kidney360. 2024 Aug 1;5(8):1072-1074. doi: 10.34067/KID.0000000000000422. Epub 2024 Apr 9.
2
Torsemide is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: Commentary.托拉塞米是心力衰竭患者更合适的口服袢利尿剂：评论
Kidney360. 2024 Aug 1;5(8):1075-1076. doi: 10.34067/KID.0000000000000442. Epub 2024 Apr 9.
3
Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: CON.托拉塞米是心力衰竭患者更合适的口服袢利尿剂：赞成。
Kidney360. 2024 Aug 1;5(8):1069-1071. doi: 10.34067/KID.0000000000000342.
4
Use of the loop diuretic torsemide in three dogs with advanced heart failure.在三只患有晚期心力衰竭的犬中使用襻利尿剂托拉塞米。
J Vet Cardiol. 2011 Dec;13(4):287-92. doi: 10.1016/j.jvc.2011.10.001. Epub 2011 Oct 24.
5
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?心力衰竭中呋塞米在襻利尿剂治疗中的主导地位：是时候重新审视其他选择了吗？
J Am Coll Cardiol. 2013 Apr 9;61(14):1549-50. doi: 10.1016/j.jacc.2012.12.043.
6
Loop diuretics in patients with heart failure: time to change to torsemide?心力衰竭患者使用袢利尿剂：是时候改用托拉塞米了吗？
J Cardiovasc Pharmacol. 2009 Jun;53(6):435-7. doi: 10.1097/FJC.0b013e3181a71a78.
7
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.托拉塞米与呋塞米用于心力衰竭患者的比较：来自杜克大学医院的见解
J Cardiovasc Pharmacol. 2015 May;65(5):438-43. doi: 10.1097/FJC.0000000000000212.
8
Torsemide as a Primary Choice in Edema Associated with Heart Failure.托塞米作为心力衰竭相关水肿的首选药物。
J Assoc Physicians India. 2024 Sep;72(9S):19-23. doi: 10.59556/japi.72.0672.
9
[Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].[高血压、高血压性心脏病与心力衰竭。袢利尿剂的作用]
Med Clin (Barc). 2008 Nov 15;131(17):660-4. doi: 10.1157/13128726.
10
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).托拉塞米与呋塞米用于急性心力衰竭患者的疗效比较（来自ASCEND-HF试验）
Am J Cardiol. 2016 Feb 1;117(3):404-11. doi: 10.1016/j.amjcard.2015.10.059. Epub 2015 Nov 18.

引用本文的文献

1
Torsemide is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: Commentary.托拉塞米是心力衰竭患者更合适的口服袢利尿剂：评论
Kidney360. 2024 Aug 1;5(8):1075-1076. doi: 10.34067/KID.0000000000000442. Epub 2024 Apr 9.

本文引用的文献

1
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.托塞米与呋塞米对心力衰竭住院患者症状和生活质量的影响：TRANSFORM-HF 随机临床试验。
Circulation. 2023 Jul 11;148(2):124-134. doi: 10.1161/CIRCULATIONAHA.123.064842. Epub 2023 May 22.
2
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.托塞米与呋塞米出院后对心力衰竭住院患者全因死亡率的影响：TRANSFORM-HF 随机临床试验。
JAMA. 2023 Jan 17;329(3):214-223. doi: 10.1001/jama.2022.23924.
3
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.射血分数降低的心力衰竭患者的利尿剂变化、医疗资源利用及临床结局：来自心力衰竭患者管理改变注册研究
Circ Heart Fail. 2021 Nov;14(11):e008351. doi: 10.1161/CIRCHEARTFAILURE.121.008351. Epub 2021 Oct 22.
4
A reappraisal of loop diuretic choice in heart failure patients.心力衰竭患者袢利尿剂选择的重新评估
Am Heart J. 2015 Mar;169(3):323-33. doi: 10.1016/j.ahj.2014.12.009. Epub 2015 Jan 6.
5
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?心力衰竭中呋塞米在襻利尿剂治疗中的主导地位：是时候重新审视其他选择了吗？
J Am Coll Cardiol. 2013 Apr 9;61(14):1549-50. doi: 10.1016/j.jacc.2012.12.043.
6
Diuretics for heart failure.用于治疗心力衰竭的利尿剂
Cochrane Database Syst Rev. 2012 Feb 15(2):CD003838. doi: 10.1002/14651858.CD003838.pub3.
7
Diuretics: an update on the pharmacology and clinical uses.利尿剂：药理学和临床应用的最新进展。
Am J Ther. 2009 Jan-Feb;16(1):74-85. doi: 10.1097/MJT.0b013e31818d3f67.
8
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.托拉塞米与呋塞米用于纽约心脏病协会心功能II至IV级的慢性心力衰竭初级护理患者——疗效与生活质量
Eur J Heart Fail. 2003 Dec;5(6):793-801. doi: 10.1016/s1388-9842(03)00150-8.
9
Torasemide in chronic heart failure: results of the TORIC study.托拉塞米治疗慢性心力衰竭：TORIC研究结果
Eur J Heart Fail. 2002 Aug;4(4):507-13. doi: 10.1016/s1388-9842(02)00122-8.
10
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.托拉塞米与呋塞米治疗心力衰竭患者的开放标签随机试验。
Am J Med. 2001 Nov;111(7):513-20. doi: 10.1016/s0002-9343(01)00903-2.